...
首页> 外文期刊>Journal of experimental & clinical cancer research : >A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juices
【24h】

A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juices

机译:三维微阵列技术对内镜超声引导下细针抽吸标本和胰液进行基因分析的初步结果

获取原文
           

摘要

Background Analysis of gene expression and gene mutation may add information to be different from ordinary pathological tissue diagnosis. Since samples obtained endoscopically are very small, it is desired that more sensitive technology is developed for gene analysis. We investigated whether gene expression and gene mutation analysis by newly developed ultra-sensitive three-dimensional (3D) microarray is possible using small amount samples from endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) specimens and pancreatic juices. Methods Small amount samples from 17 EUS-FNA specimens and 16 pancreatic juices were obtained. After nucleic acid extraction, the samples were amplified with labeling and analyzed by the 3D microarray. Results The analyzable rate with the microarray was 46% (6/13) in EUS-FNA specimens of RNAlater? storage, and RNA degradations were observed in all the samples of frozen storage. In pancreatic juices, the analyzable rate was 67% (4/6) in frozen storage samples and 20% (2/10) in RNAlater? storage. EUS-FNA specimens were classified into cancer and non-cancer by gene expression analysis and K-ras codon 12 mutations were also detected using the 3D microarray. Conclusions Gene analysis from small amount samples obtained endoscopically was possible by newly developed 3D microarray technology. High quality RNA from EUS-FNA samples were obtained and remained in good condition only using RNA stabilizer. In contrast, high quality RNA from pancreatic juice samples were obtained only in frozen storage without RNA stabilizer.
机译:基因表达和基因突变的背景分析可能会增加与普通病理组织诊断不同的信息。由于内窥镜下获得的样品非常小,因此希望开发出更灵敏的技术来进行基因分析。我们调查了是否可以使用内窥镜超声引导下的细针抽吸(EUS-FNA)标本和胰液中的少量样品,通过新开发的超灵敏三维(3D)微阵列进行基因表达和基因突变分析。方法从17份EUS-FNA标本和16份胰液中提取少量样品。核酸提取后,将样品标记扩增并通过3D微阵列分析。结果在RNAlater的EUS-FNA标本中,微阵列分析率为46%(6/13)。 存储,并且在所有冷冻存储样本中均观察到RNA降解。在胰液中,冷冻保存样品的可分析率是67%(4/6),而RNAlater中的可分析率是20%(2/10)。 存储。 EUS-FNA标本通过基因表达分析分为癌症和非癌症,并且使用3D微阵列还检测到K-ras密码子12突变。结论通过最新开发的3D微阵列技术可以从内窥镜下获得的少量样品进行基因分析。从EUS-FNA样品获得了高质量的RNA,仅使用RNA稳定剂即可保持良好状态。相反,胰腺汁样品中的高质量RNA仅在没有RNA稳定剂的冷冻储存中获得。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号